Collaboration

  • PBC Biomed Attends MÉDI’NOV CONNECTION Event

    , ,

    PBC Biomed and Enterprise Ireland France joined forces at the MÉDI’NOV CONNECTION event in Lyon this morning, ahead of two days of networking and workshops. Pictured below from left to right are; John Shiel – Technology Development Advisor at EI, PBC Biomed Marketing Executive – Zahia Boukanoucha, Grace Kelly – Market Executive at EI France,…

    Read More...

  • PBC Biomed attend University of Limerick ‘Employer in Residence’ Exhibition Day.

    ,

    PBC Biomed is part of the University of Limerick‘s ‘Employer-in-Residence’ programme, allowing us to connect with students who are interested in pursing a career in Medical Devices, and would like to gain some experience within the area. Our HR specialist Ross Callaghan attended an Employer-in-Residence exhibition day last week with one of our UL Co-Op…

    Read More...

  • DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.

    , , , ,

    Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®.  PBC Biomed leads a consortium for this development project, which is…

    Read More...

  • PBC Biomed had the pleasure of hosting our Clinical Advisory Board at the Medical Education & Research Institute in Memphis last week, for a development lab focused on OsStic®.

    ,

    The feedback and insights shared by this group are critical in supporting our development and educational objectives for OsStic®, which was recently awarded #BreakthroughDevice Designation. The group also looked at our other innovation programmes, including a #disruptive technology focused on nerve repair, as well as multiple new hardware concepts. Our R&D team have been working closely with our surgeon…

    Read More...

  • Collaboration with Curasan AG on Musculoskeletal Regeneration

    ,

    Shannon, Ireland, 8 June, 2021: PBC Biomed, an Irish-based Medical Device Company, have entered a partnership agreement with Curasan AG, a German-headquartered Medical Device company with global distribution, to develop innovative products in the field of musculoskeletal regeneration. This collaboration will bring together two pioneers in the advancement of biomimetic technologies to create an expanded…

    Read More...

  • Collaboration by RCSI, MTU and PBC for Degenerative Bone Disease Solution

    , ,

    RCSI, MTU and PBC BioMed to collaborate on degenerative bone disease solution RCSI University of Medicine and Health Sciences, Munster Technological University and Irish SME, PBC BioMed are to collaborate on a medical device to address the degenerative bone disease, avascular necrosis. The project is supported by an Enterprise Ireland Innovation Partnership and will develop…

    Read More...

  • DSM and PBC Partnership to develop regenerative bone adhesives

    ,

    DSM and PBC Biomed partner to develop regenerative bone adhesives for safer, more cost-effective surgical procedures. Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and PBC Biomed, a medical device design and development company, have signed an agreement to jointly design and develop novel materials for medical devices. Initially, the agreement…

    Read More...

  • Biomimetic Innovations, a collaboration between long time friends and colleagues

    ,

    We are delighted to announce the launch of Biomimetic Innovations , a collaboration between long time friends and colleagues, to further develop OsStic™ our biomimetic adhesive for tissue repair. Read More ..’In Vivo Safety Assessment of a Bio-Inspired Bone Adhesive’ J Mater Sci Mater Med 2020, 31(2):24

    Read More...